OncoPrecision
- | Biotech or pharma, therapeutic R&D
OncoPrecision is a platform therapeutics company leveraging patient-derived single-cell high-throughput biology + AI/ML to develop a pipeline of therapeutic antibodies (ADCs and BsAbs) to address areas of unmet medical need, primarily in oncology. The platform’s clinically-validated predictive power promotes a high PoS across the discovery spectrum by generating compelling translational human data before entering the clinic. The company was spun out of Dr. Gastón Soria’s Synthetic Lethality in Cancer Lab with a successful track record of Target ID and Drug Discovery collaborations with Pharma (GSK and Novartis).
Address
New YorkNew York
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}